The pharmaceutical company said it remained confident in the benefit and risk profile of Blenrep and will continue to work ...

An important point about the updated guidelines is the emphasis on individualized treatment of complicated UTIs, recognizing ...

More than half of severe COVID-19 survivors show fibrotic-like lung abnormalities even 3 years after infection, especially ...

U.S. bank Wells Fargo has suspended all travel to China after one of its employees was barred from leaving the country, a ...

AstraZeneca (AZN) announced Enhertu in combination with pertuzumab has been granted Breakthrough Therapy Designation in the U ...

Astrazeneca (AZN) closed the most recent trading day at $69.26, moving 1.17% from the previous trading session.

The decline in the company's share price came as its shares traded ex-date following the announcement of a ₹32 per share ...

AstraZeneca has briefed councillors on their plans to build a new office and conference centre at the Cambridge Biomedical ...

Summit Therapeutics' HARMONi trial data for ivonescimab showed a clinical benefit but narrowly missed statistical ...

U.S. bank Wells Fargo has suspended all travel to China after one of its employees was barred from leaving the country, ...

Sino Biopharma will acquire LaNova Medicines, which has licensed cancer drugs for Merck and AstraZeneca, for $951 million.

In the Phase III CARES trials, anselamimab did not meet the primary endpoint for advanced-stage AL amyloidosis, but a ...